Balanced news tone
News Sentiment
TRIB sentiment intelligence
Trinity Biotech plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
+2.7% over one week, -40.5% over four weeks, trend inactive, and below fair value.
Price to book forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
Price to book forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0
This article provides financial data for Trinity Biotech plc Sponsored ADR (FWB:TRB0) on the Frankfurt Stock Exchange. Specifically, it focuses on the "Price to book forward" metric. The content appears to be a snapshot from a financial information platform, likely TradingView, p
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 06:10
- Source
- TradingView
Enterprise value to EBIT forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0
The article provides financial information for Trinity Biotech plc Sponsored ADR, identified by the ticker FWB:TRB0 on the Frankfurt Stock Exchange. It specifically highlights the "Enterprise value to EBIT forward" metric for the company. The content appears to be a financial dat
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 18:40
- Source
- TradingView
Price to earnings forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0
This article provides financial data for Trinity Biotech plc Sponsored ADR (FWB:TRB0) on the Frankfurt Stock Exchange, specifically focusing on its forward price-to-earnings ratio. It indicates that the market was closed at the time of publication with no trades, offering a snaps
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Jul 2026 08:40
- Source
- TradingView
TRINITY BIOTECH PLC-SPON ADR (TRIB) Stock Chart
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jul 2026 00:00
- Source
- ChartMill
Trinity Biotech To Carry Out 1-for-30 Reverse Stock Split On July 24th, 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 23:55
- Source
- Moomoo
Trinity Biotech stock holds its setup. Investors wait for the next filing.
Trinity Biotech (TRIB) is a Nasdaq-listed small-cap diagnostics company whose stock performance is currently anchored by its listing, investor materials, and product portfolio. The company specializes in diagnostic products for clinical laboratory and point-of-care testing. Inves
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 16:40
- Source
- AD HOC NEWS
Trinity Biotech PLC Today's Market Trends | TRIB Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey
Trinity Biotech PLC (TRIB) is a commercial-stage biotechnology company focused on diabetes management and human diagnostics, including HIV tests. Despite weak market performance over the past month, the company shows strong fundamentals and technician scores, boasting high profit
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 Jul 2026 09:43
- Source
- TradingKey
Trinity Biotech CGM+ detects false low glucose alerts during sleep By Investing.com
Trinity Biotech plc announced that its CGM+ wearable biosensor platform can detect nocturnal compression-related false low glucose events, which can cause significant issues for diabetes management. The company developed an algorithm combining glucose measurements with other phys
- Tone
- Positive 61/100
- Event
- Market update
- Published
- 02 Jul 2026 23:39
- Source
- Investing.com South Africa
Trinity Biotech Unveils Clinical Trial Data Showing CGM+ Tackles Major CGM User Problem By Going Beyond Glucose-Only Monitoring
Trinity Biotech plc has released clinical trial data for its CGM+ solution, demonstrating its ability to differentiate between false low glucose readings caused by nocturnal compression and true blood glucose lows. This multi-sensor approach, validated by over 5,000 hours of clin
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 02 Jul 2026 13:11
- Source
- www.marketscreener.com
Trinity Biotech CGM+ detects false low glucose alerts during sleep
Trinity Biotech plc announced that its CGM+ wearable biosensor platform can identify false low glucose events caused by nocturnal compression during sleep. The company developed an algorithm combining glucose measurements with other physiological signals to differentiate true low
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 13:11
- Source
- Investing.com
Trinity Biotech (NASDAQ: TRIB) unveils CGM+ data targeting false low CGM alarms
Trinity Biotech (NASDAQ: TRIB) announced new clinical trial data for its CGM+ wearable biosensor platform, showing it can differentiate nocturnal compression-related false low glucose readings from true lows. This multi-sensor system, which combines glucose measurements with addi
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 02 Jul 2026 12:11
- Source
- Stock Titan
Trinity Biotech says CGM+ can spot overnight false lows from sleep pressure
Trinity Biotech (TRIB) announced clinical trial data showing its CGM+ wearable biosensor can distinguish between false low glucose alarms caused by compression during sleep and true blood glucose lows. This multi-sensor system combines glucose with other physiological signals and
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 02 Jul 2026 12:11
- Source
- Stock Titan
TRIB - Trinity Biotech Plc ADR Volatility & Greeks
This article provides a detailed financial overview of Trinity Biotech Plc ADR (TRIB), including key financial metrics, stock performance, and volatility data. It lists the last closing price, market capitalization, income, sales, and various ratios, alongside insider ownership a
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:39
- Source
- Finviz
New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring
Trinity Biotech plc announced clinical trial data for its CGM+ wearable biosensor, demonstrating its ability to differentiate nocturnal compression-related false low glucose events from true lows. This multi-sensor technology, which combines glucose measurements with other physio
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 02 Jul 2026 07:30
- Source
- Market source
Price to earnings forward of Trinity Biotech plc – NASDAQ:TRIB
This page from TradingView displays financial information for Trinity Biotech plc (NASDAQ: TRIB), specifically focusing on its forward price-to-earnings ratio. The content indicates that the market for TRIB was closed with no trades. The site provides various market analysis tool
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jul 2026 09:43
- Source
- TradingView
Trinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling
Trinity Biotech's subsidiary, Trinovium, has gained Silver Membership in the Open Compute Project (OCP), a significant step that provides access to the global AI data center ecosystem. This membership will help Trinovium accelerate product development, gain accreditation, and acc
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 01 Jul 2026 04:40
- Source
- AI Magazine
Trinity Biotech’s AI cooling unit wins Open Compute Project backing
Trinity Biotech (Nasdaq: TRIB) announced that its AI data center liquid cooling subsidiary, Trinovium, has secured Silver Membership in the Open Compute Project (OCP). This membership provides Trinovium with direct engagement with leading hyperscale operators and technology firms
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 12:40
- Source
- Stock Titan
Trinity Biotech (TRIB) gains OCP Silver Membership for AI data center cooling
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Stock Titan
Trinity Biotech Terminates Equity Credit Facility With Yorkville
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 29 Jun 2026 19:51
- Source
- MT Newswires
Trinity Biotech (TRIB) terminates Yorkville standby equity purchase agreement
Trinity Biotech plc has terminated its Standby Equity Purchase Agreement with YA II PN, LTD., an affiliate of Yorkville Advisors Global, which previously provided an equity line of credit facility. The company stated it no longer intends to utilize this facility, reflecting a shi
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 29 Jun 2026 20:11
- Source
- Stock Titan
Trinity Biotech cuts off Yorkville equity line of credit
Trinity Biotech (TRIB) has terminated its Standby Equity Purchase Agreement (SEPA) with Yorkville Advisors Global, ending its related equity line of credit facility. The company states it no longer intends to use the SEPA, and this decision aligns with its current financing strat
- Tone
- Positive 67/100
- Event
- Balance sheet
- Published
- 29 Jun 2026 19:11
- Source
- Stock Titan
Trinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville
Trinity Biotech plc (Nasdaq: TRIB) has formally terminated its Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD., an affiliate of Yorkville Advisors Global. The company has decided it will no longer utilize this equity line of credit facility, reflecting a shift in its
- Tone
- Positive 63/100
- Event
- Balance sheet
- Published
- 29 Jun 2026 19:11
- Source
- The Manila Times
Price to sales forward of Trinity Biotech plc – NASDAQ:TRIB
This article provides a brief financial snippet for Trinity Biotech plc (NASDAQ: TRIB), specifically focusing on its forward price-to-sales ratio. It indicates that the market was closed with no trades when this information was captured. The content is presented in the context of
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 10:40
- Source
- TradingView
Price to book forward of Trinity Biotech plc – NASDAQ:TRIB
This article provides financial information for Trinity Biotech plc (NASDAQ:TRIB), specifically focusing on its "Price to book forward" metric. The content is presented within the TradingView platform, offering an overview of the company's financials for investors and analysts. I
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 02:39
- Source
- TradingView
Trinity Biotech Plc Sponsored ADR Class A Actuals & Estimates (NASDAQ:TRIB)
This page provides financial actuals and estimates for Trinity Biotech plc (NASDAQ: TRIB), including reported financial data and analyst estimates across various financial statements and valuation metrics. Users can compare actual results with average, high, and low estimates and
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 22:09
- Source
- TradingView
Form 6K Trinity Biotech plc For: 23 June By Investing.com
This article announces the filing of Form 6K by Trinity Biotech plc for June 23rd. It notes that the article was updated on June 23, 2026, and provides a disclaimer regarding the high risks associated with trading financial instruments and cryptocurrencies. The content emphasizes
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 17:39
- Source
- Investing.com South Africa
Trinity Biotech launches Trinovium liquid cooling subsidiary
Trinity Biotech (NASDAQ:TRIB) has launched Trinovium, a new subsidiary specializing in advanced liquid cooling fluids and intelligence systems for AI data centers. This move positions Trinity Biotech to tap into the rapidly growing liquid cooling market, projected to reach $27 bi
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 23 Jun 2026 13:09
- Source
- grafa.com
Trinity Biotech (NASDAQ: TRIB) registers 33.75M ADS resale; launches Trinovium
Trinity Biotech (NASDAQ: TRIB) has registered a resale of up to 33.75 million American Depositary Shares (ADSs) by selling shareholders, which does not generate proceeds for the company. Concurrently, Trinity Biotech launched Trinovium, a new subsidiary focused on providing liqui
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 12:10
- Source
- Stock Titan
Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market
Trinity Biotech has launched Trinovium, a new subsidiary leveraging its expertise in ultra-high-purity fluid manufacturing for advanced liquid cooling solutions in AI data centers. This move positions Trinity Biotech in the rapidly expanding data center liquid cooling market, pro
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 23 Jun 2026 11:11
- Source
- Market source